Gastrointestinal Metabolic Surgery for the Treatment of Diabetic Patients: A Multi-Institutional International Study

Journal of Gastrointestinal Surgery

Volumn 16, Issue 1, 2012, Pages 45-52

  Lee, Wei Jei ^a   Hur, Kyung Yul ^b   Lakadawala, Muffazal ^c   Kasama, Kazunori ^d   Wong, Simon K H ^e   Lee, Yi Chih ^a,f  

^a MIN SHENG GENERAL HOSPITAL   (Taiwan)

^b Soonchunhyang University College of Medicine   (South Korea)

^c SAIFEE HOSPITAL   (India)

^d Yotsuya Medical Cube ^*  (Japan)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f CHING YUN UNIVERSITY   (Taiwan)

Author keywords

Gastrointestinal metabolic surgery; Type 2 diabetes mellitus

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; ARTIFICIAL NEURAL NETWORK; ASIA; BARIATRIC SURGERY; BLOOD; BODY MASS; CLINICAL TRIAL; FEMALE; GASTRECTOMY; GASTROPLASTY; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REMISSION; STATISTICAL MODEL; STOMACH BYPASS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; ASIA; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GASTROPLASTY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEURAL NETWORKS (COMPUTER); OBESITY; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84855346711     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1740-2     Document Type: Article

References (40)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21: 1414-1431.
2. Zimmer P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
3. Diabetes Control and Complications Trial. The relationship of glycemic exposure (HbA sub1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995; 44: 968-983.
4. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
5. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPD 34). Lancet 1998; 352: 854-865.
6. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation provides to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 1995; 222: 339-352.
7. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetes subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 358-363.
8. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-485.
9. Sjostrom L, Lindroos AK, Peltonen M, Scia DA, Clore JN. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. NEJM 2004; 351: 2683-2693.
10. Gumbs AA, Modlin IM, Ballantyne GH. Changed in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005; 15: 462-473.
11. Vidal J, Ibarzabai F, Romero F, Deigado S, Momblan D, Lacy FA. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008; 18: 1077-1082.
12. Lee Wj, Lee YC, Ser KH, Chen JC, Chen SC. Effect of diabetes resolution after bariatric surgery in Asian patients. World J Surg 2009; 18: 1119-1125.
13. Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit Consensus Conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010; 251: 399-405.
14. 2: a tailored approach. Surg Obes Related Diseas 2006; 2: 401-404.
15. Depaula AL, Macedo ALV, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endos 2007; 22: 706-716.
16. 2. J Gastrointest Surg 2008; 12: 945-952.
17. 2. Surg Obes & Related Dis 2010; 6: 332-339.
18. Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg 2010; 252: 559-567.
19. Wang W, Wei PL, Lee YC et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg 2005; 15: 648-654.
20. Lee WJ, Yu PY, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 2005; 242: 20-28.
21. Lee WJ, Wang W, Yu PJ et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg 2006; 16: 586-91.
22. Ser KH, Lee WJ, Lee YC, et al. Laparoscopic sleeve gastrectomy. Surg Endos 2010; 24: 2253-2259.
23. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-2135.
24. Cybenko G. Approximation by superpositions of a sigmoidal Function. Math Control Signal 1989; 2: 303-314.
25. Hornik K, Stinchcombe M, White H. Multilayer feed forward networks are universal approximations. Neural Networks 1989; 2: 336-359.
26. Zervos E, Agle SC, Warren AJ, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 2010; 210: 564-574.
27. 2: An integrative review of early studies. Obes Surg 2010; 20: 776-790.
28. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316-323.
29. Rosenthal R, Li X, Samuel S, et al. Effects of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Related Diseas 2009; 5: 429-434.
30. Hall TC, Pellen MGC, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010; 20: 1245-1250.
31. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-5.
32. Lee WJ, Lee YC, Ser KH, et al. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg 2008; 18: 1119-1125.
33. Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: Efficacy and change of insulin secretion. Surgery 2010; 147: 664-669.
34. Dietel M. Surgery for diabetes at lower BMI: some caution (Editorial). Obesity Surg 2008; 18: 1211-1214.
35. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010; 375: 408-418.
36. Chang HY, Hsu CC, Pan WH, et al. Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. Diabetes Res & Clin Prac 2010; 90: 358-364.
37. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140.
38. Yokoyama H, Yamada H, Okudaira M, et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDDM patients. Diabetes Care 1998; 21: 1080-1085.
39. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes & Related Dis 2010; 6: 249-253.
40. Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes & Reated Dis 2010; 6: 254-259.